Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

Abbott Labs dismissed from Johnson & Johnson suit against Boston Scientific

U.S. District Judge Gerard Lynch in Manhattan dismissed a request byBoston Scientific, the parent company of medical device providerGuidant, which sought a dismissal of the Johnson & Johnson lawsuitagainst Guidant for breach of contract on Aug. 29.

Margins cut for cardiac monitoring and diagnostic services market

North American cardiac monitoring and diagnostic service providers arefacing difficult times due to declining reimbursement levels despitethe growing prevalence of cardiovascular disease, according to marketresearch firm Frost & Sullivan.

AngioDynamics names Bucci as chairman of the board

Interventional device development firm AngioDynamics reported that itsboard of directors has elected Vincent Bucci as its chairman.

CryoCor concludes enrollment for atrial fibrillation study

Cryoablation technology device developer CryoCor said that it hascompleted the enrollment of its clinical study for the treatment ofatrial fibrillation, which includes more than 170 patients.

Boston Scientific amends credit, prepays $1 billion on loan

Interventional device developer Boston Scientific of Natick, Mass.,reported that it has successfully amended its $2 billion revolving lineof credit and $5 billion term-loan agreement.

GE unable to deliver Ceretec due to inclement weather

GE Healthcare announced to customers that it will experience animpending shortage in its Ceretec (technetium Tc-99m exametazime)supply due to the flooding of its manufacturing site in Gloucester,England, which will be temporarily closed.

Medtronic cardiovascular unit shows Q1 growth

Medical device manufacturer Medtronic’s cardiovascular business unitreported a positive uptick in revenues for its fiscal 2008 firstquarter (end-July 27, 2007) compared with the same quarter last year.

Endologix completes infrarenal cuff enrollment

Interventional device developer Endologix reported that it hascompleted its enrollment of a multicenter, nonrandomized, controlledInvestigational Device Exemption clinical trial.

Displaying 1593 - 1600 of 1765

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup